Tweet
Health Secur. 2017 May/Jun;15(3):244-252. doi: 10.1089/hs.2016.0129.
Personal Protective Equipment Supply Chain: Lessons Learned from Recent Public Health Emergency Responses.
Patel A, D'Alessandro MM, Ireland KJ, Burel WG, Wencil EB, Rasmussen SA.
Abstract
Personal protective equipment (PPE) that protects healthcare workers from infection is a critical component of infection control strategies in healthcare settings. During a public health emergency response, protecting healthcare workers from infectious disease is essential, given that they provide clinical care to those who fall ill, have a high risk of exposure, and need to be assured of occupational safety. Like most goods in the United States, the PPE market supply is based on demand. The US PPE supply chain has minimal ability to rapidly surge production, resulting in challenges to meeting large unexpected increases in demand that might occur during a public health emergency. Additionally, a significant proportion of the supply chain is produced off-shore and might not be available to the US market during an emergency because of export restrictions or nationalization of manufacturing facilities. Efforts to increase supplies during previous public health emergencies have been challenging. During the 2009 H1N1 influenza pandemic and the 2014 Ebola virus epidemic, the commercial supply chain of pharmaceutical and healthcare products quickly became critical response components. This article reviews lessons learned from these responses from a PPE supply chain and systems perspective and examines ways to improve PPE readiness for future responses.
KEYWORDS:
Ebola; Pandemic influenza; Personal protective equipment; Public health preparedness/response; Supply chain
PMID: 28636443 DOI: 10.1089/hs.2016.0129
Personal Protective Equipment Supply Chain: Lessons Learned from Recent Public Health Emergency Responses.
Patel A, D'Alessandro MM, Ireland KJ, Burel WG, Wencil EB, Rasmussen SA.
Abstract
Personal protective equipment (PPE) that protects healthcare workers from infection is a critical component of infection control strategies in healthcare settings. During a public health emergency response, protecting healthcare workers from infectious disease is essential, given that they provide clinical care to those who fall ill, have a high risk of exposure, and need to be assured of occupational safety. Like most goods in the United States, the PPE market supply is based on demand. The US PPE supply chain has minimal ability to rapidly surge production, resulting in challenges to meeting large unexpected increases in demand that might occur during a public health emergency. Additionally, a significant proportion of the supply chain is produced off-shore and might not be available to the US market during an emergency because of export restrictions or nationalization of manufacturing facilities. Efforts to increase supplies during previous public health emergencies have been challenging. During the 2009 H1N1 influenza pandemic and the 2014 Ebola virus epidemic, the commercial supply chain of pharmaceutical and healthcare products quickly became critical response components. This article reviews lessons learned from these responses from a PPE supply chain and systems perspective and examines ways to improve PPE readiness for future responses.
KEYWORDS:
Ebola; Pandemic influenza; Personal protective equipment; Public health preparedness/response; Supply chain
PMID: 28636443 DOI: 10.1089/hs.2016.0129